Mind Medicine MindMed Inc. buy Royal Bank of Canada
Start price
23.10.23
/
50%
€2.50
Target price
23.10.24
€6.57
Performance (%)
102.80%
Price
04.10.24
€5.07
Summary
This prediction is currently active. With a performance of 102.80% the BUY prediction by Royal_Bank_of_Canada is a big success. This prediction currently runs until 23.10.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Mind Medicine MindMed Inc. | -3.152% | -3.152% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Mind Medicine MindMed Inc. diskutieren
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $7.00 price target on the stock.
Ratings data for MNMD provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Mind Medicine MindMed Inc.
Mind Medicine MindMed Inc.
Start price
Target price
Perf. (%)
€6.61
05.06.24
05.06.24
€20.24
05.06.25
05.06.25
-23.24%
04.10.24
04.10.24
Mind Medicine MindMed Inc.
Start price
Target price
Perf. (%)
€5.23
29.02.24
29.02.24
€13.89
28.02.25
28.02.25
-2.97%
04.10.24
04.10.24
Mind Medicine MindMed Inc.
Start price
Target price
Perf. (%)
€3.95
04.08.23
04.08.23
€6.34
04.08.24
04.08.24
86.55%
05.08.24
05.08.24
Mind Medicine MindMed Inc.
Start price
Target price
Perf. (%)
€2.84
13.03.23
13.03.23
€4.66
13.03.24
13.03.24
193.66%
14.03.24
14.03.24